4.5 Article

Structural Genomic Variation as Risk Factor for Idiopathic Recurrent Miscarriage

Journal

HUMAN MUTATION
Volume 35, Issue 8, Pages 972-982

Publisher

WILEY
DOI: 10.1002/humu.22589

Keywords

recurrent miscarriage; fetomaternal interface; immune dysfunction; placenta; GOLPH3; PDZD2

Funding

  1. Wellcome Trust International Senior Research Fellowship in Biomedical Science in Central Europe [070191/Z/03/A]
  2. Estonian Ministry of Education and Research Core Grants [SF0180022s12, SF0180026s09, SF0180142s08]
  3. European Union through the European Regional Development Fund (project HAPPY PREGNANCY) [3.2.0701.12-0047]
  4. Estonian Science Foundation Grant [ETF9030]
  5. EU ERDF through the Estonian Centre of Excellence in Genomics
  6. European Commission FP7 project (gEU-VADIS) [261123]

Ask authors/readers for more resources

Recurrent miscarriage (RM) is a multifactorial disorder with acknowledged genetic heritability that affects similar to 3% of couples aiming at childbirth. As copy number variants (CNVs) have been shown to contribute to reproductive disease susceptibility, we aimed to describe genome-wide profile of CNVs and identify common rearrangements modulating risk to RM. Genome-wide screening of Estonian RM patients and fertile controls identified excessive cumulative burden of CNVs (5.4 and 6.1 Mb per genome) in two RM cases possibly increasing their individual disease risk. Functional profiling of all rearranged genes within RM study group revealed significant enrichment of loci related to innate immunity and immunoregulatory pathways essential for immune tolerance at fetomaternal interface. As a major finding, we report a multicopy duplication (61.6 kb) at 5p13.3 conferring increased maternal risk to RM in Estonia and Denmark (meta-analysis, n = 309/205, odds ratio = 4.82, P = 0.012). Comparison to Estonian population-based cohort (total, n = 1000) confirmed the risk for Estonian female cases (P = 7.9 x 10-4). Datasets of four cohorts from the Database of Genomic Variants (total, n = 5,846 subjects) exhibited similar low duplication prevalence worldwide (0.7%-1.2%) compared to RM cases of this study (6.6%-7.5%). The CNV disrupts PDZD2 and GOLPH3 genes predominantly expressed in placenta and it may represent a novel risk factor for pregnancy complications. Published 2014 Wiley Periodicals, Inc.*

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available